Drug Profile
Research programme: lipid-emulsion therapeutics - ResQ Pharma
Alternative Names: LipidRescue TherapyLatest Information Update: 28 Sep 2021
Price :
$50
*
At a glance
- Originator ResQ Pharma
- Class Lipids
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Poisoning
Most Recent Events
- 28 Sep 2021 No recent reports of development identified for preclinical development in Poisoning in Ireland (IV, Infusion)
- 30 Sep 2019 Preclinical trials in Poisoning is ongoing in Ireland (Infusion) (ResQ Pharma pipeline, September 2019)
- 15 Jun 2017 Research programme: lipid-emulsion therapeutics - ResQ Pharma receives Orphan Drug status for Poisoning in USA